Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Megan S. Lim, MD, PhD, Karen Pulford, PhD, FRCPath, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Marsha C. Kinney, MD, Sherrie L. Perkins, MD, PhD, James R. Anderson, PhD, Lynette Smith, MS, Mitchell S. Cairo, MD, Sheila Weitzman, MB, Thomas G. Gross, MD, PhD, Jacqueline M. Kraveka, DO

Blood (2010) 116 (21): 4130.

https://doi.org/10.1182/blood.V116.21.4130.4130

Published: 2010

Journal Articles

Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies

Andrew J Campbell, MD, PhD, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Martin Barnardo, FRCPath, Amanda P Liggins, BSc, PhD, Maite Caibes, BSc, Alison Banham, DPhil, Graham Collins, MD, PhD, Chris S.R Hatton, MD, Karen Pulford, PhD, FRCPath

Blood (2010) 116 (21): 4294.

https://doi.org/10.1182/blood.V116.21.4294.4294

Published: 2010

Journal Articles

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Kamel Ait-Tahar, Christine Damm-Welk, Birgit Burkhardt, Martin Zimmermann, Wolfram Klapper, Alfred Reiter, Karen Pulford, Wilhelm Woessmann

Blood (2010) 115 (16): 3314–3319.

https://doi.org/10.1182/blood-2009-11-251892

Published: 2010

Includes: Supplemental data

Journal Articles

Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma

Karen Pulford, Christine Damm-Welk, Birgit Burkhardt, Martin Zimmerman, Alfred Reiter, Kamel Ait-Tahar, Wilhelm Woessmann

Blood (2008) 112 (11): 2831.

https://doi.org/10.1182/blood.V112.11.2831.2831

Published: 2008

Journal Articles

Identification of Huntingtin Interacting Protein 1 Related (HIP1R) as a Novel Lymphoma Autoantigen Using Antigen Array Profiling

Kah-Keng Wong, Karen Pulford, Hong Chen, Derek Murphy, Alison Banham

Blood (2008) 112 (11): 3757.

https://doi.org/10.1182/blood.V112.11.3757.3757

Published: 2008

Journal Articles

Nucleophosmin (NPM) Has Increased Expression and Shuttling Activity in Chronic Lymphocytic Leukaemia without Somatic Hypermutation of the Immunoglubulin Gene (UM-CLL) and Is Linked to Ribosomal Proteins: A Possible Role for Increased Protein biosynthesis in the Adverse Outcome of UM-CLL.

Karen S Rees-Unwin, PhD, Robin Faragher, PhD, Claire V Hutchinson, FRCPath, Richard D Unwin, PhD, Julie Adams, PhD, Andrew Pettitt, PhD, FRCPath, Alison H Banham, PhD, Karen Pulford, PhD, John Burthem, PhD, FRCPath

Blood (2008) 112 (11): 2082.

https://doi.org/10.1182/blood.V112.11.2082.2082

Published: 2008

Journal Articles

The Voltage-Gated Proton Channel HVCN1 Co-Localizes with B Cell Receptor and Is Involved in Class Switch Recombination in Vivo

Melania Capasso, Mandeep K Bhamrah, Robert S Boyd, Kelvin Cain, Karen Pulford, Boris Musset, Vladimir V Cherny, Deri Morgan, Thomas E DeCoursey, Randy D Gascoyne, Martin JS Dyer

Blood (2008) 112 (11): 707.

https://doi.org/10.1182/blood.V112.11.707.707

Published: 2008

Journal Articles

Potentially oncogenic B-cell activation–induced smaller isoforms of FOXP1 are highly expressed in the activated B cell–like subtype of DLBCL

Philip J. Brown, Sally L. Ashe, Ellen Leich, Christof Burek, Sharon Barrans, James A. Fenton, Andrew S. Jack, Karen Pulford, Andreas Rosenwald, Alison H. Banham

Blood (2008) 111 (5): 2816–2824.

https://doi.org/10.1182/blood-2007-09-115113

Published: 2008

Includes: Supplemental data

Journal Articles

NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma

Annamaria Galietta, Rosalind H. Gunby, Sara Redaelli, Paola Stano, Cristiana Carniti, Angela Bachi, Philip W. Tucker, Carmen J. Tartari, Ching-Jung Huang, Emanuela Colombo, Karen Pulford, Miriam Puttini, Rocco G. Piazza, Holger Ruchatz, Antonello Villa, Arianna Donella-Deana, Oriano Marin, Danilo Perrotti, Carlo Gambacorti-Passerini

Blood (2007) 110 (7): 2600–2609.

https://doi.org/10.1182/blood-2006-01-028647

Published: 2007

Includes: Supplemental data

Journal Articles

PASD1 is a potential multiple myeloma–associated antigen

Surinder S. Sahota, C. Madusha Goonewardena, Christopher D. O. Cooper, Amanda P. Liggins, Kamal Ait-Tahar, Niklas Zojer, Freda K. Stevenson, Alison H. Banham, Karen Pulford

Blood (2006) 108 (12): 3953–3955.

https://doi.org/10.1182/blood-2006-04-014621

Published: 2006

Journal Articles

Identification of Circulating Autoantibodies in Patients with Lymphoma Using Antigen Arrays.

Karen Pulford, PhD, Hong Chen, MD, Kamel Ait-Tahar, PhD, Amanda P. Liggins, PhD, Christopher D.O. Cooper, MSc, Graham Collins, MRCP, Chris S.R. Hatton, MRCPath, Edith Gould, BSc, David Toomey, PhD, Alison H. Banham, DPhil, Derek Murphy, PhD

Blood (2006) 108 (11): 2397.

https://doi.org/10.1182/blood.V108.11.2397.2397

Published: 2006

Journal Articles

Protein Expression Profiles Confirm PASD1 as a Cancer Testis Antigen and a Potential Candidate for Lymphoma Immunotherapy.

Christopher D.O. Cooper, MBiochem, MRes, Amanda P. Liggins, PhD, Kamel Ait-Tahar, PhD, Alison H. Banham, DPhil, Karen Pulford, PhD

Blood (2005) 106 (11): 2825.

https://doi.org/10.1182/blood.V106.11.2825.2825

Published: 2005

Journal Articles

Human BCL11B Is Expressed in Normal T Cells and Differentially Expressed in T-Cell Malignancies.

Karen Pulford, PhD, Linden Lyne, BSc, Giovanna Roncador, PhD, Ryo Kominami, PhD, Alison H. Banham, DPhil

Blood (2005) 106 (11): 4393.

https://doi.org/10.1182/blood.V106.11.4393.4393

Published: 2005

Journal Articles

BCL11A XL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.

Karen Pulford, PhD, Alison H. Banham, DPhil, Linden Lyne, DPhil, Margaret Jones, BSc, Greg Ippolito, PhD, Hiu Liu, BSc, Phil W. Tucker, PhD, Giovanna Roncador, PhD, Elena Lucas, BSc, Sally Ashe, PhD, Elizabeth Stockwin, PhD, Renata Walewska, PhD, Elisabeth L. Karran, PhD, Randy Gascoyne, MD, David Y. Mason, MD, Martin J.S. Dyer, FRCPath

Blood (2005) 106 (11): 4392.

https://doi.org/10.1182/blood.V106.11.4392.4392

Published: 2005

Journal Articles

Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca 2+ -dependent association with annexin VI

Blood (2005) 105 (7): 2812–2820.

https://doi.org/10.1182/blood-2004-07-2630

Published: 2005

Journal Articles

ALK is not expressed in Hodgkin disease

Sophie Camilleri-Broët, Josée Audouin, Christophe Fermé, Josette Brière, Karen Pulford, Philippe Gaulard, Marine Diviné, Elizabeth Macintyre, Georges Delsol, Françoise Berger

Blood (2001) 97 (6): 1901–1902.

https://doi.org/10.1182/blood.V97.6.1901

Published: 2001

Journal Articles

CD30 + anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features

Harald Stein, Hans-Dieter Foss, Horst Dürkop, Theresa Marafioti, Georges Delsol, Karen Pulford, Stefano Pileri, Brunangelo Falini

Blood (2000) 96 (12): 3681–3695.

https://doi.org/10.1182/blood.V96.12.3681

Published: 2000

Journal Articles

Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma

Karen Pulford, Brunangelo Falini, Alison H. Banham, Diana Codrington, Helen Roberton, Christopher Hatton, David Y. Mason

Blood (2000) 96 (4): 1605–1607.

https://doi.org/10.1182/blood.V96.4.1605

Published: 2000

Journal Articles

Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)

Christian Touriol, Catherine Greenland, Laurence Lamant, Karen Pulford, Frédéric Bernard, Thérèse Rousset, David Y. Mason, Georges Delsol

Blood (2000) 95 (10): 3204–3207.

https://doi.org/10.1182/blood.V95.10.3204

Published: 2000

Journal Articles

Lymphomas Expressing ALK Fusion Protein(s) Other Than NPM-ALK

Brunangelo Falini, Karen Pulford, Alessandra Pucciarini, Antonino Carbone, Chris De Wolf-Peeters, Jacqueline Cordell, Marco Fizzotti, Antonella Santucci, Pier-Giuseppe Pelicci, Stefano Pileri, Elias Campo, German Ott, Georges Delsol, David Y. Mason

Blood (1999) 94 (10): 3509–3515.

https://doi.org/10.1182/blood.V94.10.3509.422k36_3509_3515

Published: 1999

NARROW

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma

Identification of Huntingtin Interacting Protein 1 Related (HIP1R) as a Novel Lymphoma Autoantigen Using Antigen Array Profiling

Nucleophosmin (NPM) Has Increased Expression and Shuttling Activity in Chronic Lymphocytic Leukaemia without Somatic Hypermutation of the Immunoglubulin Gene (UM-CLL) and Is Linked to Ribosomal Proteins: A Possible Role for Increased Protein biosynthesis in the Adverse Outcome of UM-CLL.

The Voltage-Gated Proton Channel HVCN1 Co-Localizes with B Cell Receptor and Is Involved in Class Switch Recombination in Vivo

Potentially oncogenic B-cell activation–induced smaller isoforms of FOXP1 are highly expressed in the activated B cell–like subtype of DLBCL

NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma

PASD1 is a potential multiple myeloma–associated antigen

Identification of Circulating Autoantibodies in Patients with Lymphoma Using Antigen Arrays.

Protein Expression Profiles Confirm PASD1 as a Cancer Testis Antigen and a Potential Candidate for Lymphoma Immunotherapy.

Human BCL11B Is Expressed in Normal T Cells and Differentially Expressed in T-Cell Malignancies.

BCL11A XL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.

Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca 2+ -dependent association with annexin VI

ALK is not expressed in Hodgkin disease

CD30 + anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features

Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma

Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)

Lymphomas Expressing ALK Fusion Protein(s) Other Than NPM-ALK

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only